Idriss, Naglaa K <br/><br/>
Plasma haemoxygenase-1 in coronary artery disease. A comparison with angiogenin, matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-1 and vascular endothelial growth factor.  [electronic resource] 

 -  Thrombosis and haemostasis  Nov 2010 
 - 1029-37 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2567-689X 
<br/><br/><label>Standard No.: </label>10.1160/TH09-11-0802  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acute Coronary Syndrome--blood<br/>Aged<br/>Angina Pectoris--blood<br/>Biomarkers--blood<br/>Blood Platelets--enzymology<br/>Cells, Cultured<br/>Coronary Artery Disease--blood<br/>Cross-Sectional Studies<br/>Endothelial Cells--enzymology<br/>Enzyme-Linked Immunosorbent Assay<br/>Female<br/>Heme Oxygenase-1--blood<br/>Humans<br/>Linear Models<br/>Male<br/>Matrix Metalloproteinase 9--blood<br/>Middle Aged<br/>Ribonuclease, Pancreatic--blood<br/>Time Factors<br/>Tissue Inhibitor of Metalloproteinase-1--blood<br/>Tumor Necrosis Factor-alpha--metabolism<br/>Up-Regulation<br/>Vascular Endothelial Growth Factor A--blood